UNSPSC 51452501: Tetrachloroethylene

This classification denotes a carcinogenic chlorinated hydrocarbon with the molecular formula C2Cl4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier TJ904HH8SN, chemically known as 1,1,2,2-tetrachloroethylene but generally known as tetrachloroethylene, which bears US NIH Compound Identifier 31373. As of Q4 2014, TETRACHLOROETHYLENE remains the US FDA Preferred Term for this commodity. Tetrachloroethylene bears US NLM identifiers UMLS ID C0039637 and NCI Concept Code C44451. SMILES: C(=C(CL)CL)(CL)CL.

UNSPSC 51452501 Tetrachloroethylene, a Commodity code, shows little relevant recent state and local procurement activity. The two most recent opportunities tagged under this code involve pharmaceutical products — antibiotics and naloxone — that fall outside the scope of tetrachloroethylene procurement and suggest a tagging mismatch rather than active demand for the chemical itself under this code.

The Illinois Department of Public Health awarded a piggyback pharmaceutical warehouse contract to Chartwell Rx LLC on August 28, 2026, totaling $2,999,999.11 over three years for Doxycycline Hyclate 100mg and Ciprofloxacin Hydrochloride 500mg tablets through the MMCAP Infuse consortium. Seminole County, Florida issued an IFB in June 2026 (due July 26, 2023 — a date inconsistency in the source) for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to the Seminole County Community Health Building. Neither solicitation involves tetrachloroethylene or chemical procurement typical of the code's nominal scope. Business development professionals should verify whether this Commodity code reflects genuine state and local demand for tetrachloroethylene or represents a persistent data-classification issue in state procurement systems.